Search research articles
Contact Us
Filters
Showing results (41-50 of 186) with videos related to
Page
of 19
Sort By:
Journal of Clinical Pathology
|
August 25, 2025
Digital pathology and image analysis of p53 biomarker in lymphomas using two algorithms: correlation with genotype and visual inspection
Anisha Naik, Aarti Kanzaria, Xueyan Chen, et al.
Leukemia & Lymphoma
|
July 3, 2015
Radioimmunotherapy consolidation using 131I-tositumomab for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma in first remission
Mazyar Shadman, Ajay K Gopal, Britt Kammerer, et al.
Nuclear Medicine Communications
|
July 31, 2014
90Y-ibritumomab tiuxetan therapy in allogeneic transplantation in B-cell lymphoma with extensive marrow involvement and chronic lymphocytic leukemia: utility of pretransplantation biodistribution
Manuela Matesan, Joseph Rajendran, Oliver W Press, et al.
Ejhaem
|
December 18, 2024
A phase 2 study of frontline pembrolizumab in follicular lymphoma
Carrie Ho, Songli Zhu, Ted Gooley, et al.
JAMA
|
February 1, 2022
Diagnosis and Management of Multiple Myeloma: A Review
Andrew J Cowan, Damian J Green, Mary Kwok, et al.
Leukemia & Lymphoma
|
May 10, 2007
Differential effects of bexarotene on intrinsic and extrinsic pathways in TRAIL-induced apoptosis in two myeloid leukemia cell lines
Shao Xu Ying, Sudeshna Seal, Nissa Abbassi, et al.
Blood
|
April 22, 2011
⁹⁰Y-Ibritumomab tiuxetan, fludarabine, and TBI-based nonmyeloablative allogeneic transplantation conditioning for patients with persistent high-risk B-cell lymphoma
Ajay K Gopal, Katherine A Guthrie, Joseph Rajendran, et al.
Blood Research
|
October 13, 2018
Bendamustine, etoposide, and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in non-Hodgkin lymphoma
Adam M Greenbaum, Damian J Green, Leona A Holmberg, et al.
Clinical Trials (London, England)
|
May 8, 2016
Response assessment in lymphoma: Concordance between independent central review and local evaluation in a clinical trial setting
Ajay K Gopal, Barbara Pro, Joseph M Connors, et al.
Investigational New Drugs
|
June 15, 2014
Phase 1b study of otlertuzumab (TRU-016), an anti-CD37 monospecific ADAPTIR™ therapeutic protein, in combination with rituximab and bendamustine in relapsed indolent lymphoma patients
Ajay K Gopal, Stefano R Tarantolo, Naresh Bellam, et al.
Page
of 19
Search research articles
Search
Showing results (41-50 of 186) with videos related to
Sort By:
Page
of 19
Journal of Clinical Pathology
|
August 25, 2025
Digital pathology and image analysis of p53 biomarker in lymphomas using two algorithms: correlation with genotype and visual inspection
Anisha Naik, Aarti Kanzaria, Xueyan Chen, et al.
Leukemia & Lymphoma
|
July 3, 2015
Radioimmunotherapy consolidation using 131I-tositumomab for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma in first remission
Mazyar Shadman, Ajay K Gopal, Britt Kammerer, et al.
Nuclear Medicine Communications
|
July 31, 2014
90Y-ibritumomab tiuxetan therapy in allogeneic transplantation in B-cell lymphoma with extensive marrow involvement and chronic lymphocytic leukemia: utility of pretransplantation biodistribution
Manuela Matesan, Joseph Rajendran, Oliver W Press, et al.
Ejhaem
|
December 18, 2024
A phase 2 study of frontline pembrolizumab in follicular lymphoma
Carrie Ho, Songli Zhu, Ted Gooley, et al.
JAMA
|
February 1, 2022
Diagnosis and Management of Multiple Myeloma: A Review
Andrew J Cowan, Damian J Green, Mary Kwok, et al.
Leukemia & Lymphoma
|
May 10, 2007
Differential effects of bexarotene on intrinsic and extrinsic pathways in TRAIL-induced apoptosis in two myeloid leukemia cell lines
Shao Xu Ying, Sudeshna Seal, Nissa Abbassi, et al.
Blood
|
April 22, 2011
⁹⁰Y-Ibritumomab tiuxetan, fludarabine, and TBI-based nonmyeloablative allogeneic transplantation conditioning for patients with persistent high-risk B-cell lymphoma
Ajay K Gopal, Katherine A Guthrie, Joseph Rajendran, et al.
Blood Research
|
October 13, 2018
Bendamustine, etoposide, and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in non-Hodgkin lymphoma
Adam M Greenbaum, Damian J Green, Leona A Holmberg, et al.
Clinical Trials (London, England)
|
May 8, 2016
Response assessment in lymphoma: Concordance between independent central review and local evaluation in a clinical trial setting
Ajay K Gopal, Barbara Pro, Joseph M Connors, et al.
Investigational New Drugs
|
June 15, 2014
Phase 1b study of otlertuzumab (TRU-016), an anti-CD37 monospecific ADAPTIR™ therapeutic protein, in combination with rituximab and bendamustine in relapsed indolent lymphoma patients
Ajay K Gopal, Stefano R Tarantolo, Naresh Bellam, et al.
Page
of 19